Back

Randomised double-blind placebo-controlled study of the effects of candesartan versus amlodipine treatment on capillary rarefaction in patients with essential hypertension (CAMIRA Trial)

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Treatment of hypertension Treatment of hypertension ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Tarek Francis Antonios

St George's Healthcare NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

10 More presentations in this session

Presentation thumbnail
Ten-year target systolic blood pressure less than 120 mmHg for more than 65 aged hypertension patients with chronic renal disease.
Presentation thumbnail
Inhibition of left ventricular hypertrophy and normalization of cardiac contractile response in relation with oxidative stress in experimental hypertension
Professor J. Milei (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Efficacy of fixed-dose combination perindopril arginine/amlodipine switched from ineffective renin-angiotensin system inhibitor based free combinations: POTENTIAL study subanalysis.
Professor M. Glezer (Moscow, RU)
Presentation thumbnail
Pleiotropic effects of antihypertensives in genetically hypertensive rats
Professor J. Milei (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Endothelium as a target organ of therapeutic effect in women with arterial hypertension with estrogen deficiency
Doctor R. Stryuk (Moscow, RU)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Treatment of hypertension

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources